{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T07:57:07Z","timestamp":1720425427506},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,4,22]]},"DOI":"10.7759\/cureus.24389","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T20:20:02Z","timestamp":1650658802000},"source":"Crossref","is-referenced-by-count":2,"title":["Retained Placenta and Postpartum Hemorrhage: A Case Report and Review of Literature"],"prefix":"10.7759","author":[{"given":"Lucie Sorelle","family":"Tchuinte Lekuikeu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.12696","article-title":"The rule of ultrasonography in the management of retained placenta","volume":"13","author":"AlMousa R","year":"2021","unstructured":"AlMousa R, AlMuhaidib HR, Alanezi SM, Al Qahtani N. The rule of ultrasonography in the management of retained placenta. Cureus. 2021, 13:e12696. 10.7759\/cureus.12696","journal-title":"Cureus"},{"key":"ref2","unstructured":"Retained placenta. (2021). Accessed. October 11, 2021: https:\/\/americanpregnancy.org\/healthy-pregnancy\/labor-and-birth\/retained-placenta\/."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3109\/14767058.2015.1034103","article-title":"Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011","volume":"29","author":"Mogos MF","year":"2016","unstructured":"Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM. Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med. 2016, 29:1077-82. 10.3109\/14767058.2015.1034103","journal-title":"J Matern Fetal Neonatal Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2004.12.074","article-title":"Abnormal placentation: twenty-year analysis","volume":"192","author":"Wu S","year":"2005","unstructured":"Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005, 192:1458-61. 10.1016\/j.ajog.2004.12.074","journal-title":"Am J Obstet Gynecol"},{"key":"ref5","unstructured":"Placenta accreta spectrum. (2018). Accessed. June 24, 2021: https:\/\/www.acog.org\/clinical\/clinical-guidance\/obstetric-care-consensus\/articles\/2018\/12\/placenta-accreta-spectrum."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2005.06.037","article-title":"Placenta previa-accreta: risk factors and complications","volume":"193","author":"Usta IM","year":"2005","unstructured":"Usta IM, Hobeika EM, Musa AA, Gabriel GE, Nassar AH. Placenta previa-accreta: risk factors and complications. Am J Obstet Gynecol. 2005, 193:1045-9. 10.1016\/j.ajog.2005.06.037","journal-title":"Am J Obstet Gynecol"},{"key":"ref7","article-title":"The retained placenta","volume":"1","author":"Weeks AD","year":"2001","unstructured":"Weeks AD. The retained placenta. Afr Health Sci. 2001, 1:36-41.","journal-title":"Afr Health Sci"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20183359","article-title":"Successful management of total placenta previa with placenta accreta presenting with massive obstetric hemorrhage: a case report","volume":"7","author":"Chanu SM","year":"2018","unstructured":"Chanu SM, Dey B, Dey S, et al.. Successful management of total placenta previa with placenta accreta presenting with massive obstetric hemorrhage: a case report. Int J Reprod Contracep Obstetr Gynecol. 2018, 7:3417-9. 10.18203\/2320-1770.ijrcog20183359","journal-title":"Int J Reprod Contracep Obstetr Gynecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1097\/01.AOG.0000151993.83276.70","article-title":"The length of the third stage of labor and the risk of postpartum hemorrhage","volume":"105","author":"Magann EF","year":"2005","unstructured":"Magann EF, Evans S, Chauhan SP, Lanneau G, Fisk AD, Morrison JC. The length of the third stage of labor and the risk of postpartum hemorrhage. Obstet Gynecol. 2005, 105:290-3. 10.1097\/01.AOG.0000151993.83276.70","journal-title":"Obstet Gynecol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2147\/IJWH.S218933","article-title":"Retained placenta after vaginal delivery: risk factors and management","volume":"11","author":"Perlman NC","year":"2019","unstructured":"Perlman NC, Carusi DA. Retained placenta after vaginal delivery: risk factors and management. Int J Womens Health. 2019, 11:527-34. 10.2147\/IJWH.S218933","journal-title":"Int J Womens Health"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0032-1311985","article-title":"Reducing hemodynamic compromise with placental removal at 10 versus 15 minutes: a randomized clinical trial","volume":"29","author":"Magann EF","year":"2012","unstructured":"Magann EF, Niederhauser A, Doherty DA, Chauhan SP, Sandlin AT, Morrison JC. Reducing hemodynamic compromise with placental removal at 10 versus 15 minutes: a randomized clinical trial. Am J Perinatol. 2012, 29:609-14. 10.1055\/s-0032-1311985","journal-title":"Am J Perinatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2013-010505","article-title":"A novel treatment for management of a trapped placenta using intracervical nitroglycerin tablets","volume":"2013","author":"Rodgers BC","year":"2013","unstructured":"Rodgers BC, Pasternak A, Gray R. A novel treatment for management of a trapped placenta using intracervical nitroglycerin tablets. BMJ Case Rep. 2013, 2013:10.1136\/bcr-2013-010505","journal-title":"BMJ Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0756.2012.01974.x","article-title":"Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial","volume":"39","author":"Samanta A","year":"2013","unstructured":"Samanta A, Roy SG, Mistri PK, et al.. Efficacy of intra-umbilical oxytocin in the management of retained placenta: a randomized controlled trial. J Obstet Gynaecol Res. 2013, 39:75-82. 10.1111\/j.1447-0756.2012.01974.x","journal-title":"J Obstet Gynaecol Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001337.pub2","article-title":"Umbilical vein injection for management of retained placenta","author":"Nardin JM","year":"2011","unstructured":"Nardin JM, Weeks A, Carroli G. Umbilical vein injection for management of retained placenta. Cochrane Database Syst Rev. 2011, CD001337. 10.1002\/14651858.CD001337.pub2","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/83120-retained-placenta-and-postpartum-hemorrhage-a-case-report-and-review-of-literature","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:46:15Z","timestamp":1707507975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/83120-retained-placenta-and-postpartum-hemorrhage-a-case-report-and-review-of-literature"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.24389","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4,22]]}}}